Trial Profile
Study of bevacizumab biosimilar in patients with cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 05 Feb 2015 New trial record